TREA

90461170 - ACUJJERA

Follow

Information

  • Trademark
  • 90461170
  • Serial Number
    90461170
  • Filing Date
    January 12, 2021
    3 years ago
  • Transaction Date
    October 20, 2022
    2 years ago
  • Status Date
    May 23, 2022
    2 years ago
  • Published for Opposition Date
    August 24, 2021
    3 years ago
  • Location Date
    October 19, 2021
    3 years ago
Information
Mark Drawing Code
4000
Mark Identification
ACUJJERA
Case File Statements
  • GS0051: Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); Pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Biological and chemical preparations for the treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Medical reagents; Medical diagnostic reagents, assays, and test kits for testing of body fluids; Cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely, cancer, for medical use
  • GS0441: Medical services; Medical testing services; DNA screening and analysis services for medical purposes
  • GS0421: Pharmaceutical research and development; Development of pharmaceutical preparations and drugs; Development of pharmaceutical preparations and drugs for the treatment of blood diseases, bone and bone marrow diseases, and cancers; Scientific research and development; Scientific laboratory services; Medical laboratory services; Conducting clinical trials for others; Conducting clinical trial for others regarding pharmaceutical preparations and drugs in the field of blood diseases, bone and bone marrow diseases, and cancers; DNA screening and analysis services for scientific research purposes
Case File Event Statements
  • 10/19/2022 - 2 years ago
    25 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/19/2022 - 2 years ago
    24 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/19/2022 - 2 years ago
    23 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/12/2022 - 2 years ago
    22 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/12/2022 - 2 years ago
    21 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 10/12/2022 - 2 years ago
    20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/12/2022 - 2 years ago
    19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/23/2022 - 2 years ago
    18 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 5/23/2022 - 2 years ago
    17 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 10/19/2021 - 3 years ago
    16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/24/2021 - 3 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/24/2021 - 3 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/4/2021 - 3 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/22/2021 - 3 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/22/2021 - 3 years ago
    11 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/22/2021 - 3 years ago
    10 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/22/2021 - 3 years ago
    9 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/22/2021 - 3 years ago
    8 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/21/2021 - 3 years ago
    7 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/27/2021 - 3 years ago
    6 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/27/2021 - 3 years ago
    5 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 4/27/2021 - 3 years ago
    4 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/27/2021 - 3 years ago
    3 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/12/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 1/15/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP